The MARLINA-T2D trial: putting the results into clinical perspective (vol 13, pg 1, 2018)

被引：0
|
作者：
Lajara, R.
机构：
来源：
EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM | 2018年 / 13卷 / 03期
关键词：
D O I：
10.1080/17446651.2018.1466975
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：179 / 179
页数：1
相关论文
共 50 条
  • [1] The MARLINA-T2D trial: putting the results into clinical perspective
    Lajara, Rosemarie
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2018, 13 (03) : 173 - 176
  • [2] EFFECTS OF LINAGLIPTIN ON GLYCAEMIC CONTROL AND ALBUMINURIA IN TYPE 2 DIABETES - THE MARLINA-T2D™ TRIAL
    Schernthaner, G.
    Groop, P.
    Cooper, M.
    Perkovic, V
    Hocher, B.
    Kanasaki, K.
    Sharma, K.
    Stanton, R.
    Toto, R.
    Cescutti, J.
    Gordat, M.
    Meinicke, T.
    Koitka-Weber, A.
    Woerle, H.
    Eynatten, M.
    NEPHROLOGY, 2016, 21 : 60 - 60
  • [3] Effects of linagliptin on glycaemic control and albuminuria in type 2 diabetes: the MARLINA-T2D™ trial
    Schernthaner, G.
    Groop, P. -H.
    Cooper, M. E.
    Perkovic, V.
    Hocher, B.
    Kanasaki, K.
    Sharma, K.
    Stanton, R. C.
    Toto, R.
    Cescutti, J.
    Gordat, M.
    Meinicke, T.
    Koitka-Weber, A.
    Woerle, H. -J.
    von Eynatten, M.
    DIABETOLOGIA, 2016, 59 : S360 - S360
  • [4] Linagliptin and its effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: the randomized MARLINA-T2D trial
    Groop, Per-Henrik
    Cooper, Mark E.
    Perkovic, Vlado
    Hocher, Berthold
    Kanasaki, Keizo
    Haneda, Masakazu
    Schernthaner, Guntram
    Sharma, Kumar
    Stanton, Robert C.
    Toto, Robert
    Cescutti, Jessica
    Gordat, Maud
    Meinicke, Thomas
    Koitka-Weber, Audrey
    Thiemann, Sandra
    von Eynatten, Maximilian
    DIABETES OBESITY & METABOLISM, 2017, 19 (11): : 1610 - 1619
  • [5] Linagliptin reduces the diabetic nephropathy score, DN_Score, in patients with T2DM and microalbuminuria: A predefined substudy from the MARLINA-T2D™ trial
    Tseng, Tzu-Ling
    Lin, Wei-Ya
    Wang, Hsiang-Chi
    Thiemann, Sandra
    Von Eynatten, Maximilian
    Chuang, Lee-Ming
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2016, 120 : S129 - S129
  • [6] Dipeptidyl peptidase-4 inhibition with linagliptin and effects on hyperglycaemia and albuminuria in patients with type 2 diabetes and renal dysfunction: Rationale and design of the MARLINA-T2D trial
    Groop, Per-Henrik
    Cooper, Mark E.
    Perkovic, Vlado
    Sharma, Kumar
    Schernthaner, Guntram
    Haneda, Masakazu
    Hocher, Berthold
    Gordat, Maud
    Cescutti, Jessica
    Woerle, Hans-Juergen
    von Eynatten, Maximilian
    DIABETES & VASCULAR DISEASE RESEARCH, 2015, 12 (06): : 455 - 462
  • [7] Urinary Proteomics as a Tool to Identify Kidney Responders to Dipeptidyl Peptidase-4 Inhibition: A Hypothesis-Generating Analysis from the MARLINA-T2D Trial
    Siwy, Justyna
    Klein, Thomas
    Rosler, Marcel
    von Eynatten, Maximilian
    PROTEOMICS CLINICAL APPLICATIONS, 2019, 13 (02)
  • [8] Quantum engineering of transistors based on 2D materials heterostructures (vol 13, pg 520, 2018)
    Iannaccone, Giuseppe
    Bonaccorso, Francesco
    Colombo, Luigi
    Fiori, Gianluca
    NATURE NANOTECHNOLOGY, 2018, 13 (06) : 520 - 520
  • [9] ABM Clinical Protocol #29: Iron, Zinc, and Vitamin D Supplementation During Breastfeeding (vol 13, pg 398, 2018)
    Taylor, Sarah N.
    BREASTFEEDING MEDICINE, 2020, 15 (07) : 481 - 481
  • [10] T1-T2 Molecular Magnetic Resonance Imaging of Renal Carcinoma Cells Based on Nano-Contrast Agents (vol 13, pg 4607, 2018)
    Li, J.
    You, J.
    Wu, C.
    INTERNATIONAL JOURNAL OF NANOMEDICINE, 2023, 18 : 561 - 561
12345